Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV)(FSE: 7JO0) is pleased to announce the successful presentation of new data at ...
(Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, today announced the poster presentation of ...
(GLOBE NEWSWIRE) -- 23andMe Research Institute, a nonprofit medical research organization, today announced two new members of its Board of Directors. Brad Margus and Stephen Quake, D.Phil., join the ...
Detailed price information for Quince Therapeutics Inc (QNCX-Q) from The Globe and Mail including charting and trades.
DNA damage repair (DDR) enzymes, including Ataxia telangiectasia and Rad3-related protein serine/threonine kinase (ATR), are crucial for maintaining stability in cells. Inhibition of DDR enzymes has ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Quince Therapeutics, Inc. (QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of ...
About Ataxia-Telangiectasia A-T is an inherited autosomal recessive neurodegenerative and immunodeficiency disorder caused by mutations in the ATM gene, which is responsible for cell homeostatic and ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--$QNCX #biotech--Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the ...
Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. Upon cell migration in confined space, such as ...
aDepartment of Metabolic Medicine, Queensland Children’s Hospital, South Brisbane, QLD, 4101, Australia bDepartment of Paediatrics, Wesley Medical Research, Auchenflower Brisbane, QLD, 4066, Australia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback